Rare malignant epithelial tumor of liver and intrahepatic biliary tract

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

19Recruiting trials

Regulatory Watchboard

10 events

Dec 2025Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

University Hospital, Angers — NA

TrialRECRUITING

Dec 2025Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Case Comprehensive Cancer Center — PHASE2

TrialRECRUITING

Oct 2025Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

UNICANCER — PHASE2

TrialRECRUITING

Sep 2025Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer

Assistance Publique - Hôpitaux de Paris — PHASE2, PHASE3

TrialNOT YET RECRUITING

Sep 2025ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

CHA University

TrialRECRUITING

Sep 2025Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

CHA University

TrialRECRUITING

Aug 2025A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

Yongjun Chen — PHASE2

TrialRECRUITING

Jul 2025A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

Eisai Co., Ltd.

TrialRECRUITING

Jan 2025HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours

Hangzhou Hanx Biopharmaceuticals, Ltd. — PHASE1, PHASE2

TrialRECRUITING

Nov 2024Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance

Tongji Hospital

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Rare malignant epithelial tumor of liver and intrahepatic biliary tract.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Dyural 80-Lm

(METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, ISOPROPYL ALCOHOL)Orphan drugstandard

Advanced Rx Pharmacy of Tennessee, LLC

12.1 Mechanism of Action Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical...

View full treatment details on disease page →

Clinical Trial Landscape

19 active trials

3Phase 3

5Phase 2

2Phase 1

2N/A

4Unknown

2PHASE1, PHASE2

1PHASE2, PHASE3

19Total recruiting

Search clinical trials for Rare malignant epithelial tumor of liver and intrahepatic biliary tract →

Recent News & Research

No recent news articles indexed yet for Rare malignant epithelial tumor of liver and intrahepatic biliary tract.
Search PubMed for Rare malignant epithelial tumor of liver and intrahepatic biliary tract →

Browse all Rare malignant epithelial tumor of liver and intrahepatic biliary tract news →

Specialist Network

No specialists currently listed for Rare malignant epithelial tumor of liver and intrahepatic biliary tract.

View all Rare malignant epithelial tumor of liver and intrahepatic biliary tract specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles